Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 18 (13), 3695-700

Novel Benzimidazole Derivatives as Selective CB2 Agonists

Affiliations

Novel Benzimidazole Derivatives as Selective CB2 Agonists

Daniel Pagé et al. Bioorg Med Chem Lett.

Erratum in

  • Bioorg Med Chem Lett. 2008 Sep 1;18(17):4914. Payza, Keymal [corrected to Payza, Kemal]

Abstract

The preparation and evaluation of a novel class of CB2 agonists based on a benzimidazole moiety are reported. They showed binding affinities up to 1nM towards the CB2 receptor with partial to full agonist potencies. They also demonstrated good to excellent selectivity (>1000-fold) over the CB1 receptor.

Similar articles

See all similar articles

Cited by 4 PubMed Central articles

MeSH terms

LinkOut - more resources

Feedback